Bad blood: secrets and lies in a Silicon Valley startup

Book Cover
Average Rating
5 star
 
(1)
4 star
 
(0)
3 star
 
(0)
2 star
 
(0)
1 star
 
(0)
Publisher:
Varies, see individual formats and editions
Pub. Date:
Varies, see individual formats and editions
Language:
English
Description
"The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
"The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
Also in This Series
More Like This
More Copies In Prospector
Loading Prospector Copies...
More Details
Contributors:
ISBN:
9781524731656
9780593105061
9781524731663
9780525642855
Reviews from GoodReads
Loading GoodReads Reviews.
Staff View

Grouping Information

Grouped Work IDbaef1559-c66a-350a-94da-a1c38154f67e
Grouping Titlebad blood secrets and lies in a silicon valley startup
Grouping Authorjohn carreyrou
Grouping Categorybook
Grouping LanguageEnglish (eng)
Last Grouping Update2021-04-20 03:52:10AM
Last Indexed2021-04-20 04:12:30AM
Novelist Primary ISBNnone

Solr Details

accelerated_reader_point_value0
accelerated_reader_reading_level0
auth_author2Damron, Will.
authorCarreyrou, John,
author2-roleDamron, Will.
author_displayCarreyrou, John
available_at_auroraCentral
Mission Viejo
Tallyn's Reach
detailed_location_auroraCentral
Mission Viejo
Tallyn's Reach
display_description"The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"-- "The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
format_auroraBook
Book on CD
eAudiobook
eBook
format_category_auroraAudio Books
Books
eBook
idbaef1559-c66a-350a-94da-a1c38154f67e
isbn9780525642855
9780593105061
9781524731656
9781524731663
item_details
Bib IdItem IdShelf LocCall NumFormatFormat CategoryNum CopiesIs Order ItemIs eContenteContent SourceeContent FileeContent URLsubformatDetailed StatusLast CheckinLocationSub-location
ils:.b18523298.i2416656xMission Viejo338.7 Car1falsefalseAvailableOct 17, 2020mvlnf
ils:.b18523298.i24166583Mission Viejo338.7 Car1falsefalseAvailableOct 10, 2020mvlnf
overdrive:5e6a98c7-5d22-4478-9f5e-7531c563bdaa-1Online OverDrive CollectionOnline OverDriveeBookeBook1falsetrueOverDriveAdobe EPUB eBook, Kindle Book, OverDrive ReadChecked Out
overdrive:c44c8fcb-0a91-461c-ab6d-08d6fe2234bf-1Online OverDrive CollectionOnline OverDriveeAudiobookAudio Books2falsetrueOverDriveOverDrive MP3 Audiobook, OverDrive ListenAvailable Online
ils:.b18664660.i24565854CentralCOMPACT DISC 338.7 Car1falsefalseAvailableJul 30, 2019cenav
ils:.b18664660.i24566044Tallyn's ReachCOMPACT DISC 338.7 Car1falsefalseAvailableJul 22, 2019tlrav
itype_auroraAudiobook CD
Book
last_indexed2021-04-20T10:12:30.838Z
lexile_score-1
literary_formNon Fiction
literary_form_fullNon Fiction
local_callnumber_aurora338.7 Car
COMPACT DISC 338.7 Car
owning_library_auroraAurora Public Library
owning_location_auroraCentral
Mission Viejo
Tallyn's Reach
primary_isbn9781524731656
publishDate2018
record_details
Bib IdFormatFormat CategoryEditionLanguagePublisherPublication DatePhysical DescriptionAbridged
ils:.b18523298BookBooksFirst edition.EnglishAlfred A. Knopf, 2018.x, 339 pages ; 25 cm.
overdrive:5e6a98c7-5d22-4478-9f5e-7531c563bdaaeBookeBookEnglishKnopf Doubleday Publishing Group2018
overdrive:c44c8fcb-0a91-461c-ab6d-08d6fe2234bfeAudiobookAudio BooksEnglishPenguin Random House Audio Publishing Group2018
ils:.b18664660Book on CDAudio BooksUnabridged.EnglishRandom House Audio, p2018.9 audio discs (11 1/2 hr.) : digital ; 4 3/4 in.
recordtypegrouped_work
scoping_details_aurora
Bib IdItem IdGrouped StatusStatusLocally OwnedAvailableHoldableBookableIn Library Use OnlyLibrary OwnedHoldable PTypesBookable PTypesLocal Url
ils:.b18523298.i2416656xOn ShelfAvailablefalsetruetruefalsefalsetrue0, 1, 3, 20, 4, 5, 6, 7, 8, 11
ils:.b18523298.i24166583On ShelfAvailablefalsetruetruefalsefalsetrue0, 1, 3, 20, 4, 5, 6, 7, 8, 11
overdrive:5e6a98c7-5d22-4478-9f5e-7531c563bdaa-1Checked OutChecked Outfalsefalsetruefalsefalsefalse
overdrive:c44c8fcb-0a91-461c-ab6d-08d6fe2234bf-1Available OnlineAvailable Onlinefalsetruetruefalsefalsefalse
ils:.b18664660.i24565854On ShelfAvailablefalsetruetruefalsefalsetrue0, 1, 3, 4, 20, 5, 6, 7, 8, 11
ils:.b18664660.i24566044On ShelfAvailablefalsetruetruefalsefalsetrue0, 1, 3, 20, 4, 5, 6, 7, 8, 11
subject_facetAudiobooks
Case studies
DIGITAL COMPACT DISC
Fraud -- United States
Hematologic equipment industry -- United States
Holmes, Elizabeth, -- 1984-
New business enterprises -- Corrupt practices -- United States -- Case studies
Securities fraud -- United States -- Case studies
Theranos (Firm) -- History
True crime stories
title_displayBad blood : secrets and lies in a Silicon Valley startup
title_fullBad Blood Secrets and Lies in a Silicon Valley Startup
Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou
Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou
title_shortBad blood
title_subsecrets and lies in a Silicon Valley startup
topic_facetAudiobooks
Business
Corrupt practices
Fraud
Hematologic equipment industry
History
Holmes, Elizabeth
New business enterprises
Nonfiction
Securities fraud
Technology